Sexually Transmitted Disease (STD ) Diagnosis Market
Sexually Transmitted Disease (STD ) Diagnosis Market Research and Forecast 2017-2022 Update Available - Forecast 2024-2030
The global sexually transmitted disease (STD) market was estimated to USD 10,730 million in 2018 and expected to grow at a CAGR of 8.7% during the forecast period. A group of illnesses that can be transmitted from one person to another through the sharing of body fluids, vaginal fluids, blood and so forth is known as STD (Sexually Transmitted Diseases). STD include more than 25-30 infectious diseases that are spread through sexual activities. In lack of treatment or awareness these diseases can lead to major health problems such as not being able to get pregnant (infertility), permanent brain damage, heart disease, cancer, and even death as STD has no early symptoms. A person exposed to STD must undergo a diagnosis for sexually transmitted diseases in a hospital or a health clinic. Common sexual transmitted diseases include human immunodeficiency virus, chlamydia, gonorrhea, syphilis, herpes simplex virus, human papilloma virus and so on.
Updated version (2019-2025) of the report
is available @ https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size
Sexually transmitted disease market is growing at a faster pace owing to the rising incidences of unprotected sex, lack of awareness and so forth. The rising number of patients suffering from STD includes people from age group of 15 years to 24 years. Recommendations from various regulatory authorities for annual STD screening for sexually active men and women are expected to further fuel the demand for STD testing. STD screening services are now widely covered under healthcare services and are likely to augment the growth of the global STD testing market. Regulatory authorities such as the WHO, have outlined strategies for the prevention and control of STDs. Research activities are being carried out to understand the growing prevalence of STDs, particularly Syphilis, among bisexual men and gay. All of these factors are anticipated to boost the growth of the global STD (sexually transmitted disease) diagnosis market during the forecast period. Moreover, lack of knowledge related to STD and poor infrastructure provision such as labs, and equipment in underdeveloped countries such as West Africa acts as a hindering agent and blocks the growth of the global STD (Sexually Transmitted Disease) Diagnosis market.
Geographical insights:
Geographically, the market is divided into North America, Europe, Asia Pacific and Rest of the World. North America is expected to dominate the STD diagnosis market owing to favorable government initiatives in the US for STDs diagnostics, favorable healthcare infrastructure and high awareness levels. However, the demand for HPV (human papillomavirus) tests has been increasing in the past few years owing to the rising awareness to examine the growth of cancerous cell within the cervix. Asia Pacific is anticipated to be the fastest growing region for the STD diagnosis market during the forecast period due to rapid spread of human papilloma virus infection among the female population in this region. This region is accounted as a leading market for STD (Sexually Transmitted Disease) Diagnosis in terms of growth. Additionally, the rising awareness towards personal care in emerging economies of India and China is anticipated to boost the STD diagnosis market during the forecast period.
Competitive insights:
The major players profiled in the Global STD (Sexually Transmitted Disease) Diagnosis Market include- Abbott Laboratories, Affymetrix, Inc., Alere Inc., Aposcience AG, BCR Biotech Inc., Becton Dickinson And Company, Biocartis SA, Biomerieux, Bio-Rad Laboratories Inc., Cepheid Inc., Danaher Corporation, DiaSorin, Exogen Biotechnology, Inc., GenMark Diagnostics, Hologic, Inc., OraSure Technologies, Qualigen Inc., Quidel Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc. and so on.
Market segmentation:
Global STD (Sexually Transmitted Disease) Diagnosis Market is segmented on the basis of disease indication, testing devices, technology, end users and regional outlook.
- Global Sexually Transmitted Disease Market Research and Analysis, by disease indication
- Sexually Transmitted Disease Market Research and Analysis, by testing devices
- Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by technology
- Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by End Users
- Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by Region
The report covers:
- Comprehensive research methodology of global STD (Sexually Transmitted Disease) diagnosis Market.
- This report also includes detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global STD (Sexually Transmitted Disease) diagnosis market.
- Insights about market determinants which are stimulating the global STD (Sexually Transmitted Disease) diagnosis Market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS?
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING INCIDENCES AND PREVALENCE OF AIDS AND OTHER STDS
3.1.2. GROWING INCIDENCE AND PREVALENCE OF HPV INFECTION
3.1.3. GOVERNMENTS INITIATIVES TOWARDS STD
3.1.4. REIMBURSEMENT FOR STD TESTING
3.1.5. INCREASING STD SCREENING SERVICES
3.2. RESTRAINT
3.2.1. LOW AWARENESS AMONG PEOPLE
3.2.2. INADEQUATE INFRASTRUCTURE PROVISIONS SUCH AS LABS, EQUIPMENT AND SUPPLIES MAJORLY IN WEST AFRICAN COUNTRIES
3.2.3. GOVERNMENT REGULATIONS FOR THE MARKET PARTICIPANTS
3.3. OPPORTUNITY
3.3.1. NATIONAL SCREENING PROGRAMS ACROSS THE WORLD
3.3.2. COVERING UNTAPPED MARKET
3.3.3. RISING AWARENESS FOR STD AND OTHER DISORDERS
3.3.4. INITIATIVES AND DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE
4. MARKET SEGMENTATION
4.1. STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY DISEASE INDICATION
4.1.1. CHLAMYDIA TESTING
4.1.2. SYPHILIS TESTING
4.1.3. GONORRHOEA TESTING
4.1.4. HERPES SIMPLEX VIRUS TESTING
4.1.5. HUMAN PAPILLOMA VIRUS TESTING
4.1.6. HUMAN IMMUNODEFICIENCY VIRUS TESTING
4.1.7. OTHERS
4.2. STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY TESTING DEVICES
4.2.1. LABORATORY DEVICES
4.2.2. POINT OF CARE DEVICES
4.3. STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY TECHNOLOGY
4.3.1. PCRS (POLYMERASE CHAIN REACTION)
4.3.2. IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK TECHNOLOGY (ASSAY)
4.3.3. FLOW CYTOMETERS
4.3.4. DIFFERENTIAL LIGHT SCATTERING
4.3.5. ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
4.3.6. PHONE CHIPS (MICROFLUIDICS + ICT)
4.3.7. PORTABLE / BENCH TOP / RAPID DIAGNOSTIC KITS
4.4. STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY END USERS
4.4.1. GOVERNMENT ORGANIZATIONS
4.4.2. HOSPITALS
4.4.3. DIAGNOSTIC CLINICS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA-PACIFIC
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS
7. COMPANY PROFILES (COMPANY OVERVIEW, PRODUCT PORTFOLIO, RECENT DEVELOPMENTS, REVENUE ANALYSIS)
7.1. ABBOTT LABORATORIES
7.2. AFFYMETRIX, INC.
7.3. ALERE INC.
7.4. APOSCIENCE AG
7.5. BCR BIOTECH INC.
7.6. BECTON DICKINSON AND COMPANY
7.7. BIOCARTIS SA
7.8. BIOMERIEUX
7.9. BIO-RAD LABORATORIES INC.
7.10. CEPHEID INC.
7.11. DANAHER CORPORATION
7.12. DIASORIN
7.13. EXOGEN BIOTECHNOLOGY, INC.,
7.14. GENMARK DIAGNOSTICS
7.15. HOLOGIC, INC
7.16. ORASURE TECHNOLOGIES
7.17. QUALIGEN, INC.
7.18. QUIDEL CORPORATION
7.19. ROCHE DIAGNOSTICS
7.20. THERMO FISHER SCIENTIFIC INC.
TABLE # 1 GLOBAL STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY DISEASE INDICATION, 2016-2022 ($ MILLION)
TABLE # 2 GLOBAL CHLAMYDIA TESTING 2016-2022 ($ MILLION)
TABLE # 3 GLOBAL SYPHILIS TESTING 2016-2022 ($ MILLION)
TABLE # 4 GLOBAL GONORRHOEA TESTING 2016-2022 ($ MILLION)
TABLE # 5 GLOBAL HERPES SIMPLEX VIRUS TESTING 2016-2022 ($ MILLION)
TABLE # 6 GLOBAL HUMAN PAPILLOMA VIRUS TESTING 2016-2022 ($ MILLION)
TABLE # 7 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS TESTING 2016-2022 ($ MILLION)
TABLE # 8 GLOBAL OTHERS 2016-2022 ($ MILLION)
TABLE # 9 GLOBAL STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY TESTING DEVICES2016-2022 ($ MILLION)
TABLE # 10 GLOBAL LABORATORY DEVICES2016-2022 ($ MILLION)
TABLE # 11 GLOBAL POINT OF CARE DEVICES2016-2022 ($ MILLION)
TABLE # 12 GLOBAL STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY TECHNOLOGY 2016-2022 ($ MILLION)
TABLE # 13 GLOBAL PCRS (POLYMERASE CHAIN REACTION) 2016-2022 ($ MILLION)
TABLE # 14 GLOBAL IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK TECHNOLOGY (ASSAY) 2016-2022 ($ MILLION)
TABLE # 15 GLOBAL FLOW CYTOMETERS 2016-2022 ($ MILLION)
TABLE # 16 GLOBAL DIFFERENTIAL LIGHT SCATTERING 2016-2022 ($ MILLION)
TABLE # 17 GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 2016-2022 ($ MILLION)
TABLE # 18 GLOBAL PHONE CHIPS (MICROFLUIDICS + ICT) 2016-2022 ($ MILLION)
TABLE # 19 GLOBAL PORTABLE / BENCH TOP / RAPID DIAGNOSTIC KITS 2016-2022 ($ MILLION)
TABLE # 20 GLOBAL STD (SEXUALLY TRANSMITTED DISEASE) DIAGNOSIS, BY END USERS2016-2022 ($ MILLION)
TABLE # 21 GLOBAL GOVERNMENT ORGANIZATIONS2016-2022 ($ MILLION)
TABLE # 22 GLOBAL HOSPITALS2016-2022 ($ MILLION)
TABLE # 23 GLOBAL DIAGNOSTIC CLINICS2016-2022 ($ MILLION)
TABLE # 24 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2016-2022 ($ MILLION)
TABLE # 25 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2016-2022 ($ MILLION)
TABLE # 26 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY TESTING DEVICES, 2016-12022 ($ MILLION)
TABLE # 27 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2016-2022 ($ MILLION)
TABLE # 28 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY END USERS, 2016-2022 ($ MILLION)
TABLE # 29 EUROPEAN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2016-2022 ($ MILLION)
TABLE # 30 EUROPEAN MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2016-2022 ($ MILLION)
TABLE # 31 EUROPEAN MARKET RESEARCH AND ANALYSIS BY TESTING DEVICES, 2016-2022 ($ MILLION)
TABLE # 32 EUROPEAN MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2016-2022 ($ MILLION)
TABLE # 33 EUROPEAN MARKET RESEARCH AND ANALYSIS BY END USER, 2016-2022 ($ MILLION)
TABLE # 34 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY COUNTRY 2016-2022, ($ MILLION)
TABLE # 35 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION 2016-2022, ($ MILLION)
TABLE # 36 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY TESTING DEVICES 2016-2022, ($ MILLION)
TABLE # 37 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2016-2022, ($ MILLION)
TABLE # 38 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY END USER, 2016-2022, ($ MILLION)
TABLE # 39 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS BY DISEASE INDICATION, 2016-2022 ($ MILLION)
TABLE # 40 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS BY TESTING DEVICES, 2016-2022 ($ MILLION)
TABLE # 41 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2016-2022 ($ MILLION)
TABLE # 42 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS BY END USER, 2016-2022 ($ MILLION)
FIGURE # 1 GLOBAL STD DIAGNOSIS MARKET SHARE BY DISEASE INDICATION, 2016 AND 2022 (%)
FIGURE # 2 GLOBAL STD DIAGNOSIS MARKET SHARE BY TESTING DEVICES, 2016 AND 2022 (%)
FIGURE # 3 GLOBAL STD DIAGNOSIS MARKET SHARE BY TECHNOLOGY, 2016 AND 2022 (%)
FIGURE # 4 GLOBAL STD DIAGNOSIS MARKET SHARE BY GEOGRAPHY 2016 AND 2022 (%)
FIGURE # 5 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 6 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 7 CANADA MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 8 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 9 UK MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 10 GERMANY MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 11 SPAIN MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 12 FRANCE MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 13 ITALY MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 14 ROE MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 15 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 16 INDIA MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 17 CHINA MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 18 JAPAN MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 19 ROAPAC MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
FIGURE # 20 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2016-2022 ($ MILLION)
